ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1151

Clinical Manifestations of BehçEt’s Disease Depending on Sex and Age: Nationwide Japanese Registration

Takehito Ishido1, Nobuyuki Horita2, Mitsuhiro Takeno3, Mizuho Ishido1, Yohei Kirino4 and Nobuhisa Mizuki5, 1Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 2National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 3Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan, 4Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 5Yokohama City University, Yokohama, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Behcet's syndrome, regeneration and risk assessment

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Behçetfs disease (BD) has a broad spectrum of clinical phenotypes. Sex differences in BD presentation has been one of the major topics of BD epidemiology. The prevalence of BD was found not to be very different between men and women, whereas that of each symptom showed a clear difference between the sexes. However, it is important to consider age factor in discussing sex differences, because the differences are mainly caused by sex hormone environments in the reproductive age besides sex chromosome gene products. In principle, genetic factors contribute to disease phenotype more prominently in young aged onset patients than elderly ones in any diseases. On contrary, elderly individuals are more exposed environmental factors and the effects are accumulated. Unfortunately, age differences in BD was reported in few studies with smaller numbers of cases.

Methods: The database of newly registered BD was obtained from the Japanese Ministry of Health, Labour and Welfare. Patients who met International Criteria for Behçet’s Disease (ICBD) were selected and analyzed. Prevalence of manifestations was compared after stratifying by sex alone, age alone, and simultaneous sex plus age.

Results: Among 6627 ICBD cases, 2651 (40.0%) were men and 3976 (60.0%) were women with a median age of 39 years (IQR 31-50 years) (Abstract Table 1). Ocular lesion was more common in male (odds ratio (male: female) 2.64 (95%CI: 2.35-2.95, P < 0.001) and genital ulceration was more common in female (odds ratio 0.29, 95%CI 0.25-0.32, P < 0.001). Ocular lesion (P < 0.001), arthritis (P < 0.001), and vascular lesions (P < 0.001) were more frequently observed in elderly-registered patients. Contrarily, genital ulceration (P < 0.001), epididymitis of males (P = 0.023), and oral ulceration (P = 0.003) were more common in younger patients. Simultaneous assessment of sex and age revealed that male predominance of ocular involvement was found in the young adult generation, but not in patients over 70 year of age (Abstract Figure 1). A female predominance of genital ulcer was prominently observed in patients 20-59 year of age; however, the sex difference was not found in patients over 60 years of age. Sensitivity analysis using International Study Group criteria replicated the results.

Conclusion: We showed that clinical phenotype in early phase of BD was different depending on onset age and sex.

Abstract Table 1. Demographic and clinical profiles.

 

All

Intfl Criteria for Behçet’s Disease

Comparison between sexes

N

7950

6627

M 2651, F 3976

Age (year) Median

40 (IQR:31-52)

39 (IQR 31-50)

P < 0.001

Sex (Male)

3379/7950 (42.5%)

2651/6627 (40.0%)

Not available

Oral ulceration

7250/7738 (93.7%)

6500/6589 (98.6%)

OR 0.49 (0.32-0.75), P = 0.001

Skin

6289/7707 (81.6%)

5674/6530 (86.9%)

OR 0.82 (0.71-0.94), P = 0.006

Ocular

2801/7518 (37.3%)

2617/6390 (41.0%)

OR 2.58 (2.33-2.86), P < 0.001

Genital ulceration

4752/7532 (63.1%)

4716/6422 (73.4%)

OR 0.29 (0.25-0.32), P < 0.001

Positive pathergy test

1568/4772 (32.9%)

1540/4181 (36.8%)

OR 1.20 (1.05-1.36), P = 0.006

Arthritis

3717/7445 (49.9%)

3294/6301 (52.3%)

OR 0.67 (0.61-0.74), P < 0.001

Epididymitis in male

289/3032 (9.5%)

247/2397 (10.3%)

Not available

Gastrointestinal

2368/7495 (31.6%)

1785/6342 (28.1%)

OR 0.91 (0.81-1.02), P = 0.090

Vascular

746/6543 (11.4%)

683/5516 (12.4%)

OR 1.55 (1.32-1.82), P < 0.001

Neurological

1688/7509 (22.5%)

1543/6363 (24.2%)

OR 0.91 (0.81-1.02), P = 0.100

HLA-B51 positive

1609/3579 (45.0%)

1356/3044 (44.5%)

OR 1.32 (1.14-1.52), P < 0.001

Abstract Figure 1. Subgrouping by sex and age of patients who satisfied International Criteria for Behçet’s Disease criteria.


Disclosure: T. Ishido, None; N. Horita, None; M. Takeno, None; M. Ishido, None; Y. Kirino, None; N. Mizuki, None.

To cite this abstract in AMA style:

Ishido T, Horita N, Takeno M, Ishido M, Kirino Y, Mizuki N. Clinical Manifestations of BehçEt’s Disease Depending on Sex and Age: Nationwide Japanese Registration [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/clinical-manifestations-of-behcets-disease-depending-on-sex-and-age-nationwide-japanese-registration/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-manifestations-of-behcets-disease-depending-on-sex-and-age-nationwide-japanese-registration/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology